Phase II study of magrolimab combination therapies in patients with advanced triple-negative breast cancer
- DOI
- 10.1016/j.esmoop.2026.108600
- Published
- 2026-11
- Container
- ESMO Open
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2026.108600,
title = {Phase II study of magrolimab combination therapies in patients with advanced triple-negative breast cancer},
author = {Y.H. Park and H.S. Rugo and N. Chittoria and R. Sacks and J. Chiu and C. Murphy and O. Ayodele and G.M. Kim and K.S. Lee and W. Xu and R. Joshi and A. Kwong and M. Dong and Y. Zhang and R. Rong and E. Lopez Rodrigo and N. Rainey and S. Adams},
year = {2026},
journal = {ESMO Open},
doi = {10.1016/j.esmoop.2026.108600},
url = {https://doi.org/10.1016/j.esmoop.2026.108600}
}RIS
TY - JOUR TI - Phase II study of magrolimab combination therapies in patients with advanced triple-negative breast cancer AU - Y.H. Park AU - H.S. Rugo AU - N. Chittoria AU - R. Sacks AU - J. Chiu AU - C. Murphy AU - O. Ayodele AU - G.M. Kim AU - K.S. Lee AU - W. Xu AU - R. Joshi AU - A. Kwong AU - M. Dong AU - Y. Zhang AU - R. Rong AU - E. Lopez Rodrigo AU - N. Rainey AU - S. Adams PY - 2026 JO - ESMO Open DO - 10.1016/j.esmoop.2026.108600 UR - https://doi.org/10.1016/j.esmoop.2026.108600 ER -
APA
Park, Y., Rugo, H., Chittoria, N., Sacks, R., Chiu, J., Murphy, C., Ayodele, O., Kim, G., Lee, K., Xu, W., Joshi, R., Kwong, A., Dong, M., Zhang, Y., Rong, R., Rodrigo, E. L., Rainey, N., & Adams, S. (2026). Phase II study of magrolimab combination therapies in patients with advanced triple-negative breast cancer. ESMO Open. https://doi.org/10.1016/j.esmoop.2026.108600
Source records
- crossref · retrieved 2026-11-07T20:43:44.603Z